Algert Global LLC grew its position in shares of Exactech, Inc. (NASDAQ:EXAC) by 58.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,068 shares of the medical equipment provider’s stock after buying an additional 28,292 shares during the quarter. Algert Global LLC owned 0.54% of Exactech worth $2,539,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of Montreal Can bought a new position in shares of Exactech during the 2nd quarter valued at $134,000. Russell Investments Group Ltd. lifted its holdings in shares of Exactech by 13.2% during the 2nd quarter. Russell Investments Group Ltd. now owns 47,118 shares of the medical equipment provider’s stock valued at $1,405,000 after buying an additional 5,485 shares during the period. TIAA CREF Investment Management LLC lifted its holdings in shares of Exactech by 11.1% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 34,438 shares of the medical equipment provider’s stock valued at $1,026,000 after buying an additional 3,444 shares during the period. OxFORD Asset Management LLP lifted its holdings in shares of Exactech by 17.8% during the 2nd quarter. OxFORD Asset Management LLP now owns 59,972 shares of the medical equipment provider’s stock valued at $1,787,000 after buying an additional 9,082 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of Exactech by 5.3% during the 2nd quarter. Northern Trust Corp now owns 149,395 shares of the medical equipment provider’s stock valued at $4,452,000 after buying an additional 7,584 shares during the period. 66.30% of the stock is currently owned by hedge funds and other institutional investors.

EXAC has been the topic of several research analyst reports. ValuEngine cut Exactech from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Gabelli cut Exactech from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Robert W. Baird reaffirmed a “hold” rating and issued a $49.00 target price on shares of Exactech in a report on Thursday, December 7th. Zacks Investment Research cut Exactech from a “hold” rating to a “sell” rating in a report on Wednesday, October 25th. Finally, Sidoti cut Exactech from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the stock. The company presently has an average rating of “Hold” and an average price target of $49.00.

Exactech, Inc. (EXAC) opened at $50.10 on Friday. Exactech, Inc. has a twelve month low of $23.30 and a twelve month high of $50.95. The company has a market capitalization of $719.75, a price-to-earnings ratio of 41.45, a P/E/G ratio of 4.03 and a beta of 1.02. The company has a quick ratio of 2.09, a current ratio of 4.08 and a debt-to-equity ratio of 0.06.

Exactech (NASDAQ:EXAC) last announced its earnings results on Monday, October 30th. The medical equipment provider reported $0.20 EPS for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($0.03). Exactech had a return on equity of 7.22% and a net margin of 0.18%. The company had revenue of $61.40 million during the quarter, compared to the consensus estimate of $61.78 million. analysts anticipate that Exactech, Inc. will post 1.29 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This piece was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/12/15/exactech-inc-exac-shares-bought-by-algert-global-llc.html.

Exactech Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Want to see what other hedge funds are holding EXAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exactech, Inc. (NASDAQ:EXAC).

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.